Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation

NCT00986713 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT00986713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00986713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation
Lead sponsor
Capital Medical University
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2008
Completion date
October 31, 2010
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive pulmonary aspergillosis